Literature DB >> 23516300

Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.

Anthony J Filiano1, Lauren Herl Martens, Allen H Young, Brian A Warmus, Ping Zhou, Grisell Diaz-Ramirez, Jian Jiao, Zhijun Zhang, Eric J Huang, Fen-Biao Gao, Robert V Farese, Erik D Roberson.   

Abstract

Frontotemporal dementia (FTD) is a neurodegenerative disease with hallmark deficits in social and emotional function. Heterozygous loss-of-function mutations in GRN, the progranulin gene, are a common genetic cause of the disorder, but the mechanisms by which progranulin haploinsufficiency causes neuronal dysfunction in FTD are unclear. Homozygous progranulin knock-out (Grn(-/-)) mice have been studied as a model of this disorder and show behavioral deficits and a neuroinflammatory phenotype with robust microglial activation. However, homozygous GRN mutations causing complete progranulin deficiency were recently shown to cause a different neurological disorder, neuronal ceroid lipofuscinosis, suggesting that the total absence of progranulin may have effects distinct from those of haploinsufficiency. Here, we studied progranulin heterozygous (Grn(+/-)) mice, which model progranulin haploinsufficiency. We found that Grn(+/-) mice developed age-dependent social and emotional deficits potentially relevant to FTD. However, unlike Grn(-/-) mice, behavioral deficits in Grn(+/-) mice occurred in the absence of gliosis or increased expression of tumor necrosis factor-α. Instead, we found neuronal abnormalities in the amygdala, an area of selective vulnerability in FTD, in Grn(+/-) mice. Our findings indicate that FTD-related deficits resulting from progranulin haploinsufficiency can develop in the absence of detectable gliosis and neuroinflammation, thereby dissociating microglial activation from functional deficits and suggesting an important effect of progranulin deficiency on neurons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516300      PMCID: PMC3740510          DOI: 10.1523/JNEUROSCI.6103-11.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Social dominance in inbred mouse strains.

Authors:  G LINDZEY; H WINSTON; M MANOSEVITZ
Journal:  Nature       Date:  1961-07-29       Impact factor: 49.962

2.  Recognition of emotion in the frontal and temporal variants of frontotemporal dementia.

Authors:  Howard J Rosen; Katherine Pace-Savitsky; Richard J Perry; Joel H Kramer; Bruce L Miller; Robert W Levenson
Journal:  Dement Geriatr Cogn Disord       Date:  2004       Impact factor: 2.959

3.  Regulation of histone acetylation during memory formation in the hippocampus.

Authors:  Jonathan M Levenson; Kenneth J O'Riordan; Karen D Brown; Mimi A Trinh; David L Molfese; J David Sweatt
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

4.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

5.  Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient.

Authors:  S Maren; G Aharonov; M S Fanselow
Journal:  Behav Neurosci       Date:  1996-08       Impact factor: 1.912

6.  Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task.

Authors:  S F Logue; R Paylor; J M Wehner
Journal:  Behav Neurosci       Date:  1997-02       Impact factor: 1.912

7.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

8.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

9.  Behavioral disorders in the frontal and temporal variants of frontotemporal dementia.

Authors:  W Liu; B L Miller; J H Kramer; K Rankin; C Wyss-Coray; R Gearhart; L Phengrasamy; M Weiner; H J Rosen
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

10.  Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice.

Authors:  S S Moy; J J Nadler; A Perez; R P Barbaro; J M Johns; T R Magnuson; J Piven; J N Crawley
Journal:  Genes Brain Behav       Date:  2004-10       Impact factor: 3.449

View more
  66 in total

1.  The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity.

Authors:  J Nicholas Cochran; Travis Rush; Susan C Buckingham; Erik D Roberson
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

Review 2.  Myeloid Cells in the Central Nervous System.

Authors:  Jasmin Herz; Anthony J Filiano; Ashtyn Smith; Nir Yogev; Jonathan Kipnis
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

3.  Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.

Authors:  Michael E Ward; Robert Chen; Hsin-Yi Huang; Connor Ludwig; Maria Telpoukhovskaia; Ali Taubes; Helene Boudin; Sakura S Minami; Meredith Reichert; Philipp Albrecht; Jeffrey M Gelfand; Andres Cruz-Herranz; Christian Cordano; Marcel V Alavi; Shannon Leslie; William W Seeley; Bruce L Miller; Eileen Bigio; Marek-Marsel Mesulam; Matthew S Bogyo; Ian R Mackenzie; John F Staropoli; Susan L Cotman; Eric J Huang; Li Gan; Ari J Green
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

4.  Progranulin in the hematopoietic compartment protects mice from atherosclerosis.

Authors:  Andrew D Nguyen; Thi A Nguyen; Rajesh K Singh; Delphine Eberlé; Jiasheng Zhang; Jess Porter Abate; Anatalia Robles; Suneil Koliwad; Eric J Huang; Frederick R Maxfield; Tobias C Walther; Robert V Farese
Journal:  Atherosclerosis       Date:  2018-08-30       Impact factor: 5.162

Review 5.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 6.  Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders.

Authors:  Todd E Golde
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

7.  Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.

Authors:  Zoe A Klein; Hideyuki Takahashi; Mengxiao Ma; Massimiliano Stagi; Melissa Zhou; TuKiet T Lam; Stephen M Strittmatter
Journal:  Neuron       Date:  2017-07-19       Impact factor: 17.173

8.  Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia.

Authors:  Grietje Krabbe; S Sakura Minami; Jon I Etchegaray; Praveen Taneja; Biljana Djukic; Dimitrios Davalos; David Le; Iris Lo; Lihong Zhan; Meredith C Reichert; Faten Sayed; Mario Merlini; Michael E Ward; David C Perry; Suzee E Lee; Ana Sias; Christopher N Parkhurst; Wen-Biao Gan; Katerina Akassoglou; Bruce L Miller; Robert V Farese; Li Gan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 9.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 10.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.